Literature DB >> 9805657

Molecular characterization of immunoglobulin G4 gene isoallotypes.

A Brusco1, S Saviozzi, F Cinque, M DeMarchi, C Boccazzi, G de Lange, A M van Leeuwen, A O Carbonara.   

Abstract

The molecular bases of classical serological immunoglobulin allotypes are progressively uncovered through detailed characterization of the relevant genes. Here we describe two isoallotypic determinants of the G4 gene. In the first, Leu 309, as in G1 and G3, is changed to Val, as in G2; studies on myeloma proteins have long assigned the immunologically defined nG4 m(a)/(b) to the same position. The two molecular variants, here called IGHG4*L309 and IGHG4*V309, are allelic in IGHC haplotypes with a single G4 gene, but can be found together in cis in G4-duplicated haplotypes. A second isoallotypic variant was found at codon 409, where either Arg, as in G1 and G3, or Lys, as in G2, can be found. Both isoallotypes are associated with several 'silent isoallotypic' substitutions dispersed through the hinge, CH2 and CH3 domains. This suggests segmental gene conversion as the common mechanism of origin.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9805657     DOI: 10.1046/j.1365-2370.1998.00113.x

Source DB:  PubMed          Journal:  Eur J Immunogenet        ISSN: 0960-7420


  12 in total

1.  Individuals with IgG4-related disease do not have an increased frequency of the K409 variant of IgG4 that compromises Fab-arm exchange.

Authors:  Maimuna Ahmad; Vinay S Mahajan; Hamid Mattoo; John H Stone; Shiv Pillai
Journal:  J Rheumatol       Date:  2014-01       Impact factor: 4.666

2.  Estimation of polyclonal IgG4 hybrids in normal human serum.

Authors:  Elizabeth Young; Emma Lock; Douglas G Ward; Alexander Cook; Stephen Harding; Gregg L F Wallis
Journal:  Immunology       Date:  2014-07       Impact factor: 7.397

3.  Fab-arm exchange: what's in a name?

Authors:  Janine Schuurman; Aran F Labrijn; Paul W H I Parren
Journal:  MAbs       Date:  2012-09-06       Impact factor: 5.857

Review 4.  IgG subclasses and allotypes: from structure to effector functions.

Authors:  Gestur Vidarsson; Gillian Dekkers; Theo Rispens
Journal:  Front Immunol       Date:  2014-10-20       Impact factor: 7.561

5.  FcγR Binding and ADCC Activity of Human IgG Allotypes.

Authors:  Steven W de Taeye; Arthur E H Bentlage; Mirjam M Mebius; Joyce I Meesters; Suzanne Lissenberg-Thunnissen; David Falck; Thomas Sénard; Nima Salehi; Manfred Wuhrer; Janine Schuurman; Aran F Labrijn; Theo Rispens; Gestur Vidarsson
Journal:  Front Immunol       Date:  2020-05-06       Impact factor: 7.561

Review 6.  Insights into the IgG heavy chain engineering patent landscape as applied to IgG4 antibody development.

Authors:  Christophe Dumet; Jérémy Pottier; Valérie Gouilleux-Gruart; Hervé Watier
Journal:  MAbs       Date:  2019-09-26       Impact factor: 5.857

7.  Fab-arm exchange is a misnomer.

Authors:  Janardan P Pandey
Journal:  MAbs       Date:  2012-08-14       Impact factor: 5.857

8.  The forgotten tale of immunoglobulin allotypes in cancer risk and treatment.

Authors:  Janardan P Pandey; Zihai Li
Journal:  Exp Hematol Oncol       Date:  2013-02-20

9.  Structural determinants of unique properties of human IgG4-Fc.

Authors:  Anna M Davies; Theo Rispens; Pleuni Ooijevaar-de Heer; Hannah J Gould; Roy Jefferis; Rob C Aalberse; Brian J Sutton
Journal:  J Mol Biol       Date:  2013-11-06       Impact factor: 5.469

10.  Dynamics of inter-heavy chain interactions in human immunoglobulin G (IgG) subclasses studied by kinetic Fab arm exchange.

Authors:  Theo Rispens; Anna M Davies; Pleuni Ooijevaar-de Heer; Samira Absalah; Onno Bende; Brian J Sutton; Gestur Vidarsson; Rob C Aalberse
Journal:  J Biol Chem       Date:  2014-01-14       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.